Chronic non-infectious posterior uveitis: Dissecting real-world registry study of YUTIQ

Video
Conference|ASRS

Dr Ankur Shah discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021.

Dr Ankur Shah, Prairie Eye Center, Springfield, IL, discusses the key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during the American Society of Retina Specialists' annual meeting in San Antonio, Texas.

Find out what the results may mean for the future of patient care.

The American Society of Retina Specialists (ASRS) is hosting its 39th Annual Scientific Meeting from 8-12 October 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.

Related Content: Additional ASRS content | Retina | Inflammation & Infection

Recent Videos
EURETINA 2024: Andrea Govetto, MD, PhD, speaks about macular oedema and the Ramin Tadayoni Award
Ricardo Letião Guerra, MD, MSc, FICO, speaks with Hattie Hayes of Ophthalmology Times Europe
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
Related Content
A flag for the European Union outside a government building. Image credit: ©ArtJazz – stock.adobe.com

EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)

Hattie Hayes
September 20th 2024
Article

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A person with glasses and a hearing aid looks at her phone. Image credit: ©Oleksandr – stock.adobe.com

EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment

Lynda Charters
September 20th 2024
Article

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A clinician administers a COVID-19 vaccine to a patient. Both wear masks. Image credit: ©Jacob Lund – stock.adobe.com

EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination

Lynda Charters
September 19th 2024
Article

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

A human heart paired with a digital display of an echocardiogram. Image credit: ©Sergey Nivens – stock.adobe.com

EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure

Lynda Charters
September 19th 2024
Article

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

© 2024 MJH Life Sciences

All rights reserved.